The re-election of Donald Trump as the US president in 2024 in part reflects an ongoing reevaluation of America’s place in ...

Red Cat's outlook centers on Black Widow recovery in '26, revised FY25 revenue, Edge 130 shift, and Blue Ops USV upside.

BioCryst Pharmaceutical announced the acquisition of Astria Therapeutics. Click here to read more about the acquisition and ...

Discover why Invesco Food & Beverage ETF (PBJ) is a contrarian buy for 2026. Explore its defensive value and dividend ...

Adobe's revenue is highly predictable, driven by subscription-based Digital Media and Digital Experience segments. Read why ...

Fifth District manufacturing activity declined in November, according to the most recent survey from the Federal Reserve Bank ...

November’s 5% pullback is all but over now. With 0.6% left to go for a new all-time high, it seems like almost a certainty.

QQQX offers reliable income with consistent distributions and tax-efficient return of capital. Click here to read why QQQX is ...

Google's TPU chips position it as a viable Nvidia competitor, targeting a significant share of the AI data center market.

Nutex Health recently posted Q2 and Q3 results, showing strong revenue growth and operating cash flow. Read why NUTX stock is ...

After the S&P 500's big November reversal, history suggests December will likely be green too. Read more here.

I found DIVB's key strengths were on cost, diversification, and value, while it lags behind on growth and quality. Read why ...